Resmed CDI (ASX:RMD)
![ResMed Inc ASX RMD share price](https://www.raskmedia.com.au/wp-content/uploads/2019/09/ResMed-Inc-ASX-RMD-share-price.png)
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) passive income
Resmed CDI (ASX:RMD) share price news
![](https://www.raskmedia.com.au/wp-content/uploads/2022/03/asx-200-shares-news-key-takeaways-min-768x433.png)
![Drew Meredith, CFP](https://www.raskmedia.com.au/wp-content/uploads/2023/05/drew-meredith-300x300.png)
3 key investor takeaways from the week
Here are my three key investor takeaways from a shortened week that saw the S&P/ASX 200 (ASX: XJO) finish broadly flat.
![](https://www.raskmedia.com.au/wp-content/uploads/2022/03/asx-200-xjo-news-today-768x433.png)
![Drew Meredith, CFP](https://www.raskmedia.com.au/wp-content/uploads/2023/05/drew-meredith-300x300.png)
ASX 200 morning report – RHC, RIO & AGL shares in focus
The S&P/ASX 200 (ASX:XJO) finished flat on Wednesday as Ramsay Health Care (ASX:RHC) and Rio Tinto (ASX:RIO) shares were in the news.
![](https://www.raskmedia.com.au/wp-content/uploads/2022/03/asx-200-xjo-news-today-768x433.png)
![Drew Meredith, CFP](https://www.raskmedia.com.au/wp-content/uploads/2023/05/drew-meredith-300x300.png)
ASX 200 morning report – PDL, IRE & ASX lithium shares in focus
It was another weak day for the S&P/ASX 200 (ASX: XJO) on Tuesday as Pendal (ASX:PDL) and Iress (ASX:IRE) shares made headlines.
![](https://www.raskmedia.com.au/wp-content/uploads/2022/02/cathie-wood-biotech-arkg-768x432.png)
![Value Downunder](https://www.raskmedia.com.au/wp-content/uploads/2021/10/VDU-150x150.jpg)
Is it time to buy Cathie Wood’s beaten-up biotech companies (BATS:ARKG)?
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
![Growth](https://www.raskmedia.com.au/wp-content/uploads/2019/03/13832-768x564.jpg)
![Lachlan Buur-Jensen](https://www.raskmedia.com.au/wp-content/uploads/2022/01/IMG_4605-scaled-e1641179237723-150x150.jpg)
Cochlear share price (ASX:COH) rises 6% on record HY22 report
The Cochlear Limited (ASX: COH) share price has bounced this morning after recording a 28% jump in profit for the first half of FY22.
![](https://www.raskmedia.com.au/wp-content/uploads/2017/12/hello_monday_growth_positive-768x550.jpg)
![Drew Meredith, CFP](https://www.raskmedia.com.au/wp-content/uploads/2023/05/drew-meredith-300x300.png)
ASX 200 morning report – ResMed shares in focus
Australian investors had some respite on Friday, as volatility disappeared and the S&P/ASX 200 (ASX: XJO) gained 2.2% to finish the week.
![](https://www.raskmedia.com.au/wp-content/uploads/2021/04/asx-ift-768x477.jpg)
![Lachlan Buur-Jensen](https://www.raskmedia.com.au/wp-content/uploads/2022/01/IMG_4605-scaled-e1641179237723-150x150.jpg)
Resmed (ASX:RMD) boosts profit 12% – is now the time to buy shares?
Homegrown medical device company Resmed Inc (ASX: RMD) has updated the market with its Q2 results, boosting profit 12% year on year.
![monday-hello](https://www.raskmedia.com.au/wp-content/uploads/2018/03/monday-hello-e1593989720507-768x461.jpg)
![Drew Meredith, CFP](https://www.raskmedia.com.au/wp-content/uploads/2023/05/drew-meredith-300x300.png)
ASX 200 morning report – MQG, RMD & VUL shares in focus
The S&P/ASX 200 (ASX:XJO) finished the week and the month on a negative note as Macquarie (ASX:MQG) and Vulcan (ASX:VUL) shares made headlines.
![](https://www.raskmedia.com.au/wp-content/uploads/2021/03/asx-lovisa-768x512.jpg)
![Lachlan Buur-Jensen](https://www.raskmedia.com.au/wp-content/uploads/2022/01/IMG_4605-scaled-e1641179237723-150x150.jpg)
ResMed (ASX:RMD) share price on the move after Q1 update
The Resmed CDI (ASX: RMD) share price has launched into the green this morning after the business delivered its first quarter update.